Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» GW Pharmaceuticals Closes U.S. Public Offering; Cannabis-Based Medicines Progress
GW Pharmaceuticals Closes U.S. Public Offering; Cannabis-Based Medicines Progress
GW Pharmaceuticals Closes U.S. Public Offering; Cannabis-Based Medicines Progress
Submitted by
admin
on June 27, 2014 - 9:17am
Source:
Forbes
News Tags:
GW Pharma
Medical Marijuana
FDA
Headline:
GW Pharmaceuticals Closes U.S. Public Offering; Cannabis-Based Medicines Progress
Do Not Allow Advertisers to Use My Personal information
